None
Quote | Marker Therapeutics Inc. (NASDAQ:MRKR)
Last: | $4.05 |
---|---|
Change Percent: | -6.93% |
Open: | $4.4 |
Close: | $4.05 |
High: | $4.4 |
Low: | $4.02 |
Volume: | 28,440 |
Last Trade Date Time: | 04/30/2024 03:00:00 am |
News | Marker Therapeutics Inc. (NASDAQ:MRKR)
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Message Board Posts | Marker Therapeutics Inc. (NASDAQ:MRKR)
Subject | By | Source | When |
---|---|---|---|
https://finance.yahoo.com/news/marker-therapeutics-reports-mt-401-110000404.html | abracky | investorshub | 06/26/2023 4:10:50 PM |
https://www.globenewswire.com/en/news-release/2023/06/26/2694294/0/en/Marker-The | jobynimble | investorshub | 06/26/2023 1:19:31 PM |
My pleasure | jobynimble | investorshub | 06/26/2023 1:13:54 PM |
So my obvious question would be: with all | microcapbiotech | investorshub | 06/26/2023 1:10:23 PM |
non-clinical data on its lead multi-tumor-associated antigen (multiTAA)-specific | microcapbiotech | investorshub | 06/26/2023 1:04:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Marker Therapeutics Inc. Company Name:
MRKR Stock Symbol:
NASDAQ Market:
Marker Therapeutics Inc. Website:
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11th Global Summit on ...
Preliminary data from study in patients with lymphoma enrolled at City of Hope National Medical Center was presented at the 11 th Global Summit on Hematologic Malignancies in Whistler, BC, Canada Study participants tolerated initial dose level well and demonstrated durab...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...